Geode Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $603M | Buy |
3,086,308
+58,101
| +2% | +$11.3M | 0.04% | 393 |
|
|
2025
Q4 | $524M | Sell |
3,028,207
-8,278
| -0.3% | -$1.51M | 0.03% | 423 |
|
|
2025
Q3 | $576M | Buy |
3,036,485
+54,070
| +2% | +$9.6M | 0.04% | 396 |
|
|
2025
Q2 | $534M | Buy |
2,982,415
+208,261
| +8% | +$36.2M | 0.04% | 400 |
|
|
2025
Q1 | $468M | Buy |
2,774,154
+84,133
| +3% | +$13.8M | 0.04% | 410 |
|
|
2024
Q4 | $405M | Buy |
2,690,021
+73,368
| +3% | +$11.4M | 0.03% | 438 |
|
|
2024
Q3 | $405M | Buy |
2,616,653
+39,217
| +2% | +$5.86M | 0.03% | 437 |
|
|
2024
Q2 | $352M | Buy |
2,577,436
+43,864
| +2% | +$6.01M | 0.03% | 437 |
|
|
2024
Q1 | $336M | Buy |
2,533,572
+941
| +0% | +$122K | 0.03% | 458 |
|
|
2023
Q4 | $348M | Buy |
2,532,631
+59,067
| +2% | +$7.77M | 0.04% | 423 |
|
|
2023
Q3 | $301M | Buy |
2,473,564
+50,652
| +2% | +$6.75M | 0.04% | 428 |
|
|
2023
Q2 | $340M | Buy |
2,422,912
+72,447
| +3% | +$9.99M | 0.04% | 402 |
|
|
2023
Q1 | $332M | Sell |
2,350,465
-12,743
| -0.5% | -$1.82M | 0.04% | 394 |
|
|
2022
Q4 | $369M | Sell |
2,363,208
-78,773
| -3% | -$11.3M | 0.05% | 355 |
|
|
2022
Q3 | $299M | Buy |
2,441,981
+5,329
| +0.2% | +$702K | 0.05% | 381 |
|
|
2022
Q2 | $323M | Sell |
2,436,652
-229,568
| -9% | -$31.3M | 0.05% | 371 |
|
|
2022
Q1 | $364M | Buy |
2,666,220
+104,263
| +4% | +$14.5M | 0.05% | 380 |
|
|
2021
Q4 | $442M | Buy |
2,561,957
+29,288
| +1% | +$4.46M | 0.05% | 337 |
|
|
2021
Q3 | $367M | Sell |
2,532,669
-39,655
| -2% | -$5.8M | 0.05% | 367 |
|
|
2021
Q2 | $339M | Buy |
2,572,324
+223,054
| +9% | +$29.2M | 0.05% | 382 |
|
|
2021
Q1 | $301M | Buy |
2,349,270
+146,264
| +7% | +$18M | 0.05% | 388 |
|
|
2020
Q4 | $262M | Buy |
2,203,006
+47,802
| +2% | +$5.83M | 0.04% | 389 |
|
|
2020
Q3 | $246M | Buy |
2,155,204
+17,240
| +0.8% | +$2.04M | 0.05% | 348 |
|
|
2020
Q2 | $243M | Sell |
2,137,964
-64,468
| -3% | -$6.84M | 0.05% | 338 |
|
|
2020
Q1 | $177M | Buy |
2,202,432
+21,634
| +1% | +$2.24M | 0.05% | 359 |
|
|
2019
Q4 | $233M | Buy |
2,180,798
+26,726
| +1% | +$2.79M | 0.05% | 367 |
|
|
2019
Q3 | $230M | Buy |
2,154,072
+60,889
| +3% | +$6.25M | 0.05% | 340 |
|
|
2019
Q2 | $213M | Sell |
2,093,183
-95,526
| -4% | -$9.18M | 0.05% | 353 |
|
|
2019
Q1 | $197M | Buy |
2,188,709
+42,725
| +2% | +$3.7M | 0.05% | 360 |
|
|
2018
Q4 | $178M | Buy |
2,145,984
+225,712
| +12% | +$21.2M | 0.06% | 337 |
|
|
2018
Q3 | $207M | Sell |
1,920,272
-1,787
| -0.1% | -$196K | 0.06% | 320 |
|
|
2018
Q2 | $211M | Buy |
1,922,059
+36,850
| +2% | +$3.84M | 0.06% | 292 |
|
|
2018
Q1 | $189M | Buy |
1,885,209
+180,109
| +11% | +$18.4M | 0.06% | 308 |
|
|
2017
Q4 | $168M | Buy |
1,705,100
+180,982
| +12% | +$17.2M | 0.06% | 323 |
|
|
2017
Q3 | $142M | Buy |
1,524,118
+53,702
| +4% | +$5.7M | 0.05% | 349 |
|
|
2017
Q2 | $163M | Buy |
1,470,416
+23,115
| +2% | +$2.44M | 0.06% | 297 |
|
|
2017
Q1 | $142M | Buy |
1,447,301
+97,707
| +7% | +$9.31M | 0.06% | 325 |
|
|
2016
Q4 | $124M | Buy |
1,349,594
+47,632
| +4% | +$4.11M | 0.06% | 323 |
|
|
2016
Q3 | $110M | Buy |
1,301,962
+43,105
| +3% | +$3.62M | 0.06% | 343 |
|
|
2016
Q2 | $102M | Sell |
1,258,857
-20,308
| -2% | -$1.55M | 0.06% | 337 |
|
|
2016
Q1 | $91.2K | Buy |
1,279,165
+28,485
| +2% | +$1.91M | 0.05% | 363 |
|
|
2015
Q4 | $88.8M | Sell |
1,250,680
-9,751
| -0.8% | -$656K | 0.05% | 357 |
|
|
2015
Q3 | $77.3M | Buy |
1,260,431
+14,690
| +1% | +$1.03M | 0.05% | 386 |
|
|
2015
Q2 | $90.2M | Buy |
1,245,741
+84,102
| +7% | +$6.21M | 0.05% | 366 |
|
|
2015
Q1 | $89.1M | Buy |
1,161,639
+64,551
| +6% | +$4.62M | 0.05% | 366 |
|
|
2014
Q4 | $73.5M | Buy |
1,097,088
+47,080
| +4% | +$2.97M | 0.04% | 401 |
|
|
2014
Q3 | $63.6M | Sell |
1,050,008
-10,465
| -1% | -$645K | 0.04% | 412 |
|
|
2014
Q2 | $62.2M | Sell |
1,060,473
-11,366
| -1% | -$666K | 0.04% | 425 |
|
|
2014
Q1 | $62.1M | Sell |
1,071,839
-46,748
| -4% | -$2.51M | 0.04% | 412 |
|
|
2013
Q4 | $59.9M | Sell |
1,118,587
-1,558
| -0.1% | -$92.4K | 0.04% | 411 |
|
|
2013
Q3 | $69.2M | Buy |
1,120,145
+29,196
| +3% | +$1.75M | 0.06% | 345 |
|
|
2013
Q2 | $66.1M | Buy |
+1,090,949
| New | +$65M | 0.06% | 334 |
|
Other funds holding DGX
VCM
VPM
EIG
Geode Capital Management's DGX Position: Q1 2026 in Review
Geode Capital Management increased its Quest Diagnostics (DGX) stake by 1.9% in Q1 2026, buying an estimated $11.3M and bringing the position to 3,086,308 shares worth $603M. The position accounts for 0.04% of the portfolio, ranked #393.
Geode Capital Management first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Geode Capital Management held 3,086,308 shares of Quest Diagnostics worth $603M as of Q1 2026.
- Geode Capital Management bought 58,101 Quest Diagnostics shares in Q1 2026, an estimated $11.3M.
- Quest Diagnostics made up 0.04% of Geode Capital Management's portfolio in Q1 2026, its #393 holding.
- Geode Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
- 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.